Silencing endomucin in bone marrow sinusoids improves hematopoietic stem and progenitor cell homing during transplantation
Stem Cells · 2024
DOI: 10.1093/stmcls/sxae046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells, 2024. Verfasst von Yue Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Blood Diseases Institute, Xuzhou Medical University, Xuzhou 221006, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Hematopoietic Stem Cell Transplantation, RNA, Small Interfering. Die Arbeit nennt 37 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Efficient homing of infused hematopoietic stem and progenitor cells (HSPCs) into the bone marrow (BM) is the prerequisite for successful hematopoietic stem cell transplantation. However, only a small part of infused HSPCs find their way to the BM niche. A better understanding of the mechanisms that facilitate HSPC homing will help to develop strategies to improve the initial HSPC engraftment and subsequent hematopoietic regeneration. Here, we show that irradiation upregulates the endomucin expression of endothelial cells in vivo and in vitro. Furthermore, depletion of endomucin in irradiated endothelial cells with short-interfering RNA (siRNA) increases the HSPC-endothelial cell adhesion in vitro. To abrogate the endomucin of BM sinusoidal endothelial cells (BM-SECs) in vivo, we develop a siRNA-loaded bovine serum albumin nanoparticle for targeted delivery. Nanoparticle-mediated siRNA delivery successfully silences endomucin expression in BM-SECs and improves HSPC homing during transplantation. These results reveal that endomucin plays a critical role in HSPC homing during transplantation and that gene-based manipulation of BM-SEC endomucin in vivo can be exploited to improve the efficacy of HSPC transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Blood Diseases Institute, Xuzhou Medical University, Xuzhou 221006, Jiangsu, People's Republic of China.
- Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221006, Jiangsu, People's Republic of China.
- School of Medical Technology, Xuzhou Medical University, Xuzhou 221004, Jiangsu, People's Republic of China.
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu, People's Republic of China.
- School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, People's Republic of China.
ORCID-Profile: Yue Li, Lingyu Zeng
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Li, Y., Ren, M., Li, H., Zhang, Z., Yuan, K., Huang, Y., Yuan, S., Ju, W., He, Y., Xu, K., & Zeng, L. (2024). Silencing endomucin in bone marrow sinusoids improves hematopoietic stem and progenitor cell homing during transplantation. Stem Cells. https://doi.org/10.1093/stmcls/sxae046
Vancouver
Li Y, Ren M, Li H, Zhang Z, Yuan K, Huang Y, et al. Silencing endomucin in bone marrow sinusoids improves hematopoietic stem and progenitor cell homing during transplantation. Stem Cells. 2024. doi:10.1093/stmcls/sxae046
BibTeX
@article{Li2024,
author = {Li, Yue and Ren, Miao and Li, Hu and Zhang, Zuo and Yuan, Ke and Huang, Yujin and Yuan, Shengnan and Ju, Wen and He, Yuan and Xu, Kailin and Zeng, Lingyu},
title = {Silencing endomucin in bone marrow sinusoids improves hematopoietic stem and progenitor cell homing during transplantation},
journal = {Stem Cells},
year = {2024},
doi = {10.1093/stmcls/sxae046}
}
EUVIMED